Fill-Finish Pharmaceutical Contract Manufacturing Market 2024 - Market Size, Share, Growth, Business Strategies, Top Players And Forecast To 2033

Global fill-finish pharmaceutical contract manufacturing market size is expected to reach $17.1 Bn by 2028 at a rate of 9.3%, segmented as by product type, prefilled syringes, vials, cartridges, other products

Jul 1, 2024 - 13:42

0 4

Overview and Scope
Fill-finish pharmaceutical contract manufacturing refers to the outsourcing of the final stages of the pharmaceutical manufacturing process to specialized contract manufacturing organizations (CMOs).

Sizing and Forecast
The fill-finish pharmaceutical contract manufacturing market size has grown strongly in recent years. It will grow from $10.96 billion in 2023 to $11.97 billion in 2024 at a compound annual growth rate (CAGR) of 9.2%. The growth in the historic period can be attributed to increasing demand for biologics, outsourcing trends, globalization of pharmaceutical supply chains, quality assurance emphasis, cost containment measures..

The fill-finish pharmaceutical contract manufacturing market size is expected to see strong growth in the next few years. It will grow to $17.1 billion in 2028 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to emerging market opportunities, pandemic preparedness, digital transformation, sustainability and green initiatives, personalized medicine expansion.. Major trends in the forecast period include flexible manufacturing solutions, partnerships and collaborations, regulatory compliance and serialization, focus on sustainability and green practices, automation and robotics integration..

To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/fill-finish-pharmaceutical-contract-manufacturing-global-market-report

Segmentation & Regional Insights
The fill-finish pharmaceutical contract manufacturing market covered in this report is segmented –

1) By Product Type: Prefilled Syringes, Vials, Cartridges, Other Products
2) By Molecule Type: Large Molecules, Small Molecules
3) By End-User: Biopharmaceutical Companies, Pharmaceutical Companies

North America was the largest region in the fill-finish pharmaceutical contract manufacturing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the fill-finish pharmaceutical contract manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12056&type=smp

Major Driver Impacting Market Growth
Increasing demand for pharmaceutical products is expected to propel the growth of the fill-finish pharmaceutical contract manufacturing market going forward. Pharmaceutical products refer to medications or drugs that are specifically formulated to diagnose, prevent, treat, or cure diseases or medical conditions in humans or animals. Fill-finish pharmaceutical contract manufacturing is a critical service used for the aseptic filling of injectables, biologics, and other pharmaceutical products, ensuring accuracy, regulatory compliance, and streamlined manufacturing processes while maintaining product quality. For instance, in June 2022, according to the European Federation of Pharmaceutical Industries and Associations (EFPIA), a European trade association representing the pharmaceutical industry, the total pharmaceutical production in Europe accounted for $351 billion (€300,000 million) in 2021, with an increase of approximately 5% from $335.2 billion (€286,697 million) in 2020. Thus, R&D investment in the Spanish pharmaceutical business hit 1,267 million euros in 2021, a 9.2% increase over the previous year, 2020. Therefore, increasing demand for pharmaceutical products is driving the growth of the fill-finish pharmaceutical contract manufacturing market.

Key Industry Players
Major companies operating in the fill-finish pharmaceutical contract manufacturing market report are AbbVie Inc., Novartis AG, Thermo Fisher Scientific Inc., Fresenius Kabi, Abbott Laboratories, Eurofins Scientific SE, Lonza Group Ltd., Catalent Inc., Sun Pharmaceutical Industries Limited, West Pharmaceutical Services Inc., Patheon, Samsung Biologics Co.Ltd., WuXi Biologics, Piramal Pharma Solutions, Pfizer CentreOne, Recipharm AB, Emergent BioSolutions Inc., Boehringer Ingelheim BioXcellence, Corden Pharma GmbH, Aenova Group, Baxter BioPharma Solutions , FUJIFILM Diosynth Biotechnologies, AGC Biologics, Rentschler Biopharma SE, Recro Pharma Inc., Cobra Biologics Limited, Grand River Aseptic Manufacturing (GRAM), MabPlex International Ltd., Cerbios-Pharma SA, Symbiosis Pharmaceutical Services Limited.

The fill-finish pharmaceutical contract manufacturing market report table of contents includes:

1. Executive Summary

2. Fill-Finish Pharmaceutical Contract Manufacturing Market Characteristics

3. Fill-Finish Pharmaceutical Contract Manufacturing Market Trends And Strategies

4. Fill-Finish Pharmaceutical Contract Manufacturing Market - Macro Economic Scenario

5. Global Fill-Finish Pharmaceutical Contract Manufacturing Market Size and Growth

.....

32. Global Fill-Finish Pharmaceutical Contract Manufacturing Market Competitive Benchmarking

33. Global Fill-Finish Pharmaceutical Contract Manufacturing Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Fill-Finish Pharmaceutical Contract Manufacturing Market

35. Fill-Finish Pharmaceutical Contract Manufacturing Market Future Outlook and Potential Analysis

36. Appendix